REGENERON PHARMACEUTICALS (REGN) Stock Earnings Estimates
NASDAQ:REGN • US75886F1075
803.17 USD
+19.52 (+2.49%)
At close: Feb 13, 2026
797.567 USD
-5.6 (-0.7%)
After Hours: 2/13/2026, 8:00:01 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.117B 7.76% | 14.202B 8.27% | 14.343B 0.99% | 15.833B 10.39% | 17.374B 9.73% | 18.771B 8.04% | 20.287B 8.08% | 21.42B 5.58% | 22.069B 3.03% | 22.136B 0.30% | 20.745B -6.28% | |
| EBITDA YoY % growth | 4.757B -14.97% | 4.701B -1.17% | 4.419B -6.01% | 5.396B 22.12% | 6.383B 18.29% | 8.178B 28.12% | 7.599B -7.08% | 7.933B 4.40% | 11.028B 39.01% | 11.43B 3.65% | 9.495B -16.93% | |
| EBIT YoY % growth | 4.336B -17.46% | 4.218B -2.71% | 3.875B -8.13% | 4.975B 28.39% | 6.104B 22.69% | 6.914B 13.27% | 8.115B 17.37% | 9.175B 13.06% | 9.48B 3.32% | 9.702B 2.34% | 8.84B -8.88% | |
| Operating Margin | 33.05% | 29.70% | 27.02% | 31.42% | 35.13% | 36.83% | 40.00% | 42.83% | 42.96% | 43.83% | 42.61% | |
| EPS YoY % growth | 43.78 3.25% | 45.64 4.25% | 44.38 -2.76% | 46.46 4.68% | 54.70 17.75% | 61.08 11.65% | 68.80 12.65% | 74.79 8.69% | 80.71 7.92% | 82.91 2.74% | 77.31 -6.76% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 9.32 13.39% | 11.89 -7.73% | 12.17 2.91% | 12.29 7.46% | 9.68 3.85% | 14.80 24.44% | 11.96 -1.72% | 11.96 -2.68% |
| Revenue Q2Q % growth | 3.519B 16.18% | 3.839B 4.45% | 4.08B 8.68% | 4.272B 9.98% | 3.491B -0.80% | 4.021B 4.74% | 3.944B -3.33% | 3.998B -6.41% |
| EBITDA Q2Q % growth | 1.229B 68.15% | 1.759B 30.15% | 1.848B 22.50% | 1.457B -9.79% | 1.144B -6.92% | 1.695B -3.64% | 1.439B -22.13% | 1.433B -1.65% |
| EBIT Q2Q % growth | 988.86M 63.72% | 1.33B 22.07% | 1.412B 27.22% | 1.439B 34.30% | 1.015B 2.64% | 1.557B 17.07% | 1.315B -6.87% | 1.304B -9.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 11.44 -5.22% | 10.83 | 0.61 | 5.66% |
| Q3 2025 Q2Q % growth | 11.83 -5.06% | 9.78 | 2.05 | 20.96% |
| Q2 2025 Q2Q % growth | 12.89 11.51% | 8.61 | 4.28 | 49.77% |
| Q1 2025 Q2Q % growth | 8.22 -13.93% | 9.00 | -0.78 | -8.66% |
| Q4 2024 Q2Q % growth | 12.07 1.77% | 11.50 | 0.57 | 4.93% |
| Q3 2024 Q2Q % growth | 12.46 7.51% | 11.93 | 0.53 | 4.48% |
| Q2 2024 Q2Q % growth | 11.56 12.89% | 10.83 | 0.73 | 6.79% |
| Q1 2024 Q2Q % growth | 9.55 -5.35% | 10.29 | -0.74 | -7.23% |
| Q4 2023 Q2Q % growth | 11.86 -5.57% | 10.95 | 0.91 | 8.36% |
| Q3 2023 Q2Q % growth | 11.59 4.04% | 10.93 | 0.66 | 6.01% |
| Q2 2023 Q2Q % growth | 10.24 4.81% | 10.04 | 0.20 | 1.99% |
| Q1 2023 Q2Q % growth | 10.09 12.99% | 9.75 | 0.34 | 3.50% |
| Q4 2022 Q2Q % growth | 12.56 -41.09% | 10.23 | 2.33 | 22.77% |
| Q3 2022 Q2Q % growth | 11.14 -22.48% | 9.67 | 1.47 | 15.25% |
| Q2 2022 Q2Q % growth | 9.77 -62.13% | 9.02 | 0.75 | 8.33% |
| Q1 2022 Q2Q % growth | 8.93 -9.71% | 9.93 | -1.00 | -10.09% |
| Q4 2021 Q2Q % growth | 21.32 123.71% | 18.71 | 2.61 | 13.93% |
| Q3 2021 Q2Q % growth | 14.37 71.89% | 10.31 | 4.06 | 39.43% |
| Q2 2021 Q2Q % growth | 25.80 260.34% | 17.88 | 7.92 | 44.32% |
| Q1 2021 Q2Q % growth | 9.89 49.85% | 9.18 | 0.71 | 7.72% |
| Q4 2020 Q2Q % growth | 9.53 | 8.56 | 0.97 | 11.32% |
| Q3 2020 Q2Q % growth | 8.36 | 7.28 | 1.08 | 14.87% |
| Q2 2020 Q2Q % growth | 7.16 | 6.10 | 1.06 | 17.32% |
| Q1 2020 Q2Q % growth | 6.60 | 6.25 | 0.35 | 5.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 3.884B 2.51% | 3.876B | 8.3M | 0.21% |
| Q3 2025 Q2Q % growth | 3.754B 0.90% | 3.657B | 97.3M | 2.66% |
| Q2 2025 Q2Q % growth | 3.676B 3.62% | 3.35B | 325.6M | 9.72% |
| Q1 2025 Q2Q % growth | 3.029B -3.69% | 3.34B | -311M | -9.31% |
| Q4 2024 Q2Q % growth | 3.789B 10.34% | 3.824B | -34.8M | -0.91% |
| Q3 2024 Q2Q % growth | 3.721B 10.65% | 3.744B | -23.3M | -0.62% |
| Q2 2024 Q2Q % growth | 3.547B 12.32% | 3.446B | 101.1M | 2.93% |
| Q1 2024 Q2Q % growth | 3.145B -0.54% | 3.284B | -139M | -4.23% |
| Q4 2023 Q2Q % growth | 3.434B 0.57% | 3.351B | 83M | 2.48% |
| Q3 2023 Q2Q % growth | 3.363B 14.53% | 3.298B | 64.7M | 1.96% |
| Q2 2023 Q2Q % growth | 3.158B 10.53% | 3.077B | 81.1M | 2.64% |
| Q1 2023 Q2Q % growth | 3.162B 6.64% | 3.06B | 102.1M | 3.34% |
| Q4 2022 Q2Q % growth | 3.414B -31.05% | 3.188B | 226.4M | 7.10% |
| Q3 2022 Q2Q % growth | 2.936B -14.96% | 2.926B | 10.2M | 0.35% |
| Q2 2022 Q2Q % growth | 2.857B -44.40% | 2.852B | 5.2M | 0.18% |
| Q1 2022 Q2Q % growth | 2.965B 17.26% | 2.779B | 186.1M | 6.70% |
| Q4 2021 Q2Q % growth | 4.952B 104.37% | 4.598B | 353.7M | 7.69% |
| Q3 2021 Q2Q % growth | 3.453B 50.51% | 2.873B | 579.8M | 20.18% |
| Q2 2021 Q2Q % growth | 5.139B 163.24% | 3.995B | 1.144B | 28.62% |
| Q1 2021 Q2Q % growth | 2.529B 38.32% | 2.602B | -73.3M | -2.82% |
| Q4 2020 Q2Q % growth | 2.423B | 2.471B | -48.1M | -1.95% |
| Q3 2020 Q2Q % growth | 2.294B | 2.13B | 164M | 7.70% |
| Q2 2020 Q2Q % growth | 1.952B | 1.777B | 175M | 9.85% |
| Q1 2020 Q2Q % growth | 1.828B | 1.793B | 35.2M | 1.96% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -12.92% | -10.94% | 0.85% | 4.59% |
| Revenue | -0.45% | 0.74% | 2.24% | 4.54% |